The idea of using pharmacists in this way began to gain popularity in 2006 when someMedicare plans started covering medication therapy management programs, paying $1 to $2 a minute to pharmacists to review patients’ medicines with them; this year, about one in four people covered by Medicare Part D prescription drug plans will be eligible, according to agency estimates. For example, a Medicare Part D plan covered Ms. Gelinas’s medication management session at Barney’s pharmacy.
More employers and insurers also pay for pharmacists to advise patients, a role that the new health care law encourages with potential grants for such programs. In Wisconsin, for example, community pharmacists and some health plans have banded together to create a joint program, the Wisconsin Pharmacy Quality Collaborative, to standardize medication therapy management and ensure quality care.
Meanwhile Humana, which first paid for pharmacists to work with Medicare patients, expanded its coverage a few years ago. About a third of the 62,000 pharmacies in its network offer these services, and the insurer says it is studying whether a pharmacist seeing a patient in person has more impact than a phone call.
Christopher Pencak, R.Ph., J.D. graduated from Wayne State University College of Pharmacy in 1976 and practiced in a variety of settings. Mr. Pencak graduated Michigan State University College of Law, Cum Laude and Law Review, in 1982. He specializes in pharmacy law and the representation of all health professionals. Mr. Pencak loves being on the cutting edge of the evolution of pharmacy. His website can be found at http://www.pharmacylawpro.com.
Tuesday, August 17, 2010
Good Press
The New York Times has a good article on the expanded role and opportunity for pharmacists to take in patients' health care. Not only is this good press for the pharmacy profession, but it can serve to inspire you to start or expand new areas in your practice. For example,
Thursday, August 12, 2010
Genetic Information Nondiscrimination Act
I will be discussing this issue in my upcoming newsletter. If you are interested in reading the entire Genetic Information Nondiscrimination Act (GINA), I link to it here.
Subscribe to:
Posts (Atom)